The hypertrophic cardiomyopathy drug, like its competitor at Bristol-Myers Squibb, will carry a “black box” warning for its risk of causing heart failure in some patients.
Read More from Bizjournals.com Feed (2025-02-17 17:47:29)
The hypertrophic cardiomyopathy drug, like its competitor at Bristol-Myers Squibb, will carry a “black box” warning for its risk of causing heart failure in some patients.
Read More from Bizjournals.com Feed (2025-02-17 17:47:29)